12 Inflammatory Bowel Disease Clinical Trials in San Diego, CA (2026)

Q: How do I join a clinical trial in San Diego?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you.

Recruiting Inflammatory Bowel Disease Studies in San Diego

NCT05781152Recruiting

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pai...

San Diego, CAPHASE4900 participantsConnecticut Children's Medical Center

View Study Details

NCT06819878Recruiting

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) i...

San Diego, CAPHASE3600 participantsHoffmann-La Roche

View Study Details

NCT06548542Recruiting

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms i...

San Diego, CAPHASE2590 participantsAbbVie

View Study Details

NCT06819891Recruiting

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as RO7790121) in participants with moderately...

San Diego, CAPHASE3425 participantsHoffmann-La Roche

View Study Details

NCT06226883Recruiting

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately...

San Diego, CAPHASE2385 participantsMorphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

View Study Details

NCT05442567Recruiting

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this...

San Diego, CAPHASE3240 participantsTakeda

View Study Details

NCT06979336Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

The purpose of this study is to evaluate the efficacy of RO7837195 compared with placebo in participants with moderately to severely active ulcerative colitis for whom prior treatment with conventiona...

San Diego, CAPHASE2224 participantsGenentech, Inc.

View Study Details

NCT07845487Recruiting

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a placebo to see how well it works, how safe i...

San Diego, CAPHASE2204 participantsPalisade Bio

View Study Details

NCT05660746Recruiting

Precise Infliximab Exposure and Pharmacodynamic Control

Approximately 3 million people in the United States are living with inflammatory bowel disease, which includes Crohn's Disease (CD). There are limited treatment options approved for use in children an...

San Diego, CAPHASE2180 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT07071519Recruiting

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how Risankizumab...

San Diego, CAPHASE3120 participantsAbbVie

View Study Details

NCT04779320Recruiting

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedoliz...

San Diego, CAPHASE3120 participantsTakeda

View Study Details

NCT05973500Recruiting

Effect of Mediterranean Diet in Inflammatory Bowel Disease

The effects of diet on inflammatory bowel disease is an under-studied area of research. The investigators are interested in further investigating the role that diet contributes to inflammatory bowel d...

San Diego, CANA90 participantsUniversity of California, San Diego

View Study Details

About Inflammatory Bowel Disease Clinical Trials in San Diego

Inflammatory bowel disease (IBD) encompasses chronic inflammatory conditions of the gastrointestinal tract, primarily Crohn's disease and ulcerative colitis. It affects millions worldwide and can cause debilitating symptoms. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 12 inflammatory bowel disease clinical trials recruiting participants in San Diego, CA. These studies are seeking a combined 4,078 participants. Research is being sponsored by Connecticut Children's Medical Center, Hoffmann-La Roche, AbbVie and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Inflammatory Bowel Disease Clinical Trials in San Diego — FAQ

Are there inflammatory bowel disease clinical trials in San Diego?

Yes, there are 12 inflammatory bowel disease clinical trials currently recruiting in San Diego, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Diego?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.

Are clinical trials in San Diego free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.

What inflammatory bowel disease treatments are being tested?

The 12 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for inflammatory bowel disease.

Data updated October 17, 2026 from ClinicalTrials.gov